[HTML][HTML] Transforming growth factor-β stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase …

SM Käkönen, KS Selander, JM Chirgwin… - Journal of Biological …, 2002 - ASBMB
Transforming growth factor (TGF)-β promotes breast cancer metastasis to bone. To determine
whether the osteolytic factor parathyroid hormone-related protein (PTHrP) is the primary …

Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity

…, D Chen, B Shackley, KW Harris, KS Selander - Molecular cancer …, 2006 - AACR
Toll-like receptor 9 (TLR9) recognizes microbial DNA. We show here that TLR9 protein is
expressed in human breast cancer cells and clinical breast cancer samples. Stimulation of …

Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.

KS Selander, J Mönkkönen, EK Karhukorpi… - Molecular …, 1996 - ASPET
Bisphosphonates (BPs), such as clodronate and pamidronate, are inhibitors of bone resorption
and are used on a widespread basis in the treatment of hyper-resorptive bone diseases. …

Toll like receptor‐9 agonists stimulate prostate cancer invasion in vitro

…, M Zayzafoon, KW Harris, KS Selander - The …, 2007 - Wiley Online Library
BACKGROUND Toll‐like receptor 9 (TLR9) recognizes microbial DNA. In addition to immune
cells, TLR9 expression has been detected in various cancer cells. We showed recently that …

Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression

…, Y Soini, KS Selander, KS Vuopala… - Journal of innate …, 2011 - karger.com
Background: Stimulation of Toll-like receptor 9 (TLR9) has been linked to invasion in various
cancer cells in vitro. We investigated TLR9 expression in normal, dysplastic and malignant …

[HTML][HTML] Toll-like receptor 9 in breast cancer

J Sandholm, KS Selander - Frontiers in immunology, 2014 - frontiersin.org
Toll-like receptor 9 (TLR9) is a cellular DNA receptor of the innate immune system. DNA
recognition via TLR9 results in an inflammatory reaction, which eventually also activates a Th1-…

[HTML][HTML] CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer

…, GG Yegutkin, A Jukkola, J Tuomela, KS Selander - Scientific reports, 2021 - nature.com
CD73 is a cell surface ecto-5′-nucleotidase, which converts extracellular adenosine
monophosphate to adenosine. High tumor CD73 expression is associated with poor outcome …

[HTML][HTML] Toll-like receptors in esophageal cancer

JH Kauppila, KS Selander - Frontiers in immunology, 2014 - frontiersin.org
Esophageal squamous cell carcinoma and esophageal adenocarcinoma are cancers of
high mortality. EAC develops through Barrett’s esophagus (BE) and columnar dysplasia, …

Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy

KS Selander, L Li, L Watson, M Merrell, H Dahmen… - Cancer research, 2004 - AACR
The cytokine receptor gp130 is the common signaling subunit of receptors used by the
interleukin (IL)-6 cytokine family. gp130 is widely expressed in breast cancer cell lines and …

Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases

KS Selander, DA Brown, GB Sequeiros, M Hunter… - … Biomarkers & Prevention, 2007 - AACR
Macrophage-inhibitory cytokine-1 (MIC-1) is a divergent member of the transforming growth
factor β superfamily. It is up-regulated by nonsteroidal anti-inflammatory drugs and is highly …